Compugen Ltd.
A clinical-stage company developing cancer immunotherapies using an AI platform.
CGEN | TA
Overview
Corporate Details
- ISIN(s):
- IL0010852080
- LEI:
- Country:
- Israel
- Address:
- 26 Harokmim St., Bldg D, 5885849 Holon
- Website:
- https://www.cgen.com/
Description
Compugen Ltd. is a clinical-stage therapeutic discovery and development company specializing in cancer immunotherapy. A pioneer in its field, the company leverages a proprietary, broadly applicable, and predictive AI-powered computational discovery platform to identify novel drug targets. Its primary focus is on developing innovative, first-in-class therapeutics designed to modulate the tumor microenvironment and enhance anti-tumor immune responses. Compugen's mission is to advance its pipeline of drug candidates to address patient populations unresponsive to current immunotherapy treatments.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2022-05-16 15:59 |
Reports First Quarter 2022 Results
|
English | 36.0 KB | ||
| 2022-05-10 15:59 |
Mr. Ari Krashin, Chief Financial Officer and Chief Operating Officer notified t…
|
English | 70.0 KB | ||
| 2022-05-10 15:59 |
Mr. Ari Krashin, Chief Financial Officer and Chief Operating Officer notified t…
|
English | 35.8 KB | ||
| 2022-05-02 15:59 |
first quarter 2022 financial results on Monday, May 16, 2022
|
English | 85.2 KB | ||
| 2022-05-02 15:59 |
first quarter 2022 financial results on Monday, May 16, 2022
|
English | 35.9 KB | ||
| 2022-03-21 13:59 |
Compugen’s Computational Discovery Leverages Single Cell Spatial Transcriptomic…
|
English | 99.0 KB | ||
| 2022-03-21 13:59 |
Compugen’s Computational Discovery Leverages Single Cell Spatial Transcriptomic…
|
English | 35.9 KB | ||
| 2022-03-14 13:59 |
Compugen To Present New Insights into the Tumor Microenvironment Using Single C…
|
English | 97.3 KB | ||
| 2022-03-14 13:59 |
Compugen To Present New Insights into the Tumor Microenvironment Using Single C…
|
English | 35.9 KB | ||
| 2022-03-09 15:04 |
Compugen to Present at the Oppenheimer 32nd Annual Global Healthcare Conference
|
English | 84.3 KB | ||
| 2022-03-09 15:04 |
Compugen to Present at the Oppenheimer 32nd Annual Global Healthcare Conference
|
English | 35.9 KB | ||
| 2022-03-09 14:59 |
Compugen Presents New Research Suggesting Targeting DNAM-1 Axis Holds Promise f…
|
English | 97.6 KB | ||
| 2022-03-09 14:59 |
Compugen Presents New Research Suggesting Targeting DNAM-1 Axis Holds Promise f…
|
English | 35.9 KB | ||
| 2022-03-01 02:24 |
FORM 20-F/A Amendment No. 1
|
English | 2.3 MB | ||
| 2022-03-01 02:24 |
FORM 20-F/A Amendment No. 1
|
English | 36.0 KB |
Automate Your Workflow. Get a real-time feed of all Compugen Ltd. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Compugen Ltd.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Compugen Ltd. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
